• Title of article

    Comparative Proteomics Study of Streptozotocin-induced Diabetic Nephropathy in Rats’ Kidneys Transfected with Adenovirus-mediated Fibromodulin Gene

  • Author/Authors

    Maleki، Akram نويسنده Zanjan Metabolic Disease Research Center, Zanjan University of Medical Sciences , , Ramazani، Ali نويسنده , , Foroutan، Maryam نويسنده Department of Molecular Medicine & Genetics, School of Medicine, Zanjan University of Medical Sciences , , Biglari، Alireza نويسنده Department of Molecular Medicine & Genetics, School of Medicine, Zanjan University of Medical Sciences , , Ranjzad، Parisa نويسنده Vascular Gene Therapy Unit, Research School of Clinical & Laboratory Sciences, Manchester Academic Health Science Centre, The University of Manchester , , Awsat Mellati، Ali نويسنده ,

  • Issue Information
    فصلنامه با شماره پیاپی 21 سال 2014
  • Pages
    9
  • From page
    104
  • To page
    112
  • Abstract
    Background: Transforming Growth Factor-beta (TGF-β) activation appears to be crucial for tissue injury in Diabetic Nephropathy (DN). Fibromodulin, the small leucine-rich proteoglycan, has been proposed to be the potent TGF-β modulator. In this study, the therapeutic effects of fibromodulin in the kidneys of streptozotocin (STZ)-induced diabetic rats were investigated. Methods: Diabetic rats received intraperitoneal (IP) injections of recombinant adenovirus expression vectors (RAd5) containing fibromodulin (RAd-FMOD) and were killed after 10 weeks. Proteins were isolated from the rat kidney and separated using two-dimensional gel electrophoresis. The differentially expressed proteins were analyzed using Matrix-assisted laser desorption/ ionization time-of-flight mass spectrometry (MALDI-TOF-MS). Results: Ten spots were identified using MALDI-TOF-MS. The identified proteins were primarily responsible for cell metabolism, cytoskeleton formation, and oxidative stress. RAd-FMOD treatment markedly attenuated the albuminuria in diabetic rats. Conclusion: Taken together, these results provide a valuable clue in exploring the mechanism underlying the therapeutic effects of fibromodulin in diabetic nephropathy suggesting that it can be a potential agent in the treatment of this disease.
  • Journal title
    AJMB Avicenna Journal of Medical Biotechnology
  • Serial Year
    2014
  • Journal title
    AJMB Avicenna Journal of Medical Biotechnology
  • Record number

    1983371